- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Pleconaril.
Displaying page 1 of 1.
EudraCT Number: 2017-004125-32 | Sponsor Protocol Number: APOCT-004 | Start Date*: 2018-03-28 | |||||||||||
Sponsor Name:Apodemus Aktiebolag | |||||||||||||
Full Title: A randomised, double blind, placebo controlled trial to evaluate the safety, efficacy and pharmakokinetics of Pleconaril as an add on to AchEI/memantine for treatment of patients with Alzheimer’s d... | |||||||||||||
Medical condition: Alzheimer's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003350-41 | Sponsor Protocol Number: APOCT-003 | Start Date*: 2017-03-28 | |||||||||||
Sponsor Name:Division pf Paediatric and Adolescent Medicine, Oslo University Hospital | |||||||||||||
Full Title: The Diabetes Virus Detection and Intervention Trial (DiViDIntervention) | |||||||||||||
Medical condition: Newly diagnosed Type 1 Diabetes diagnosed within the previous three weeks at time of screening. Female and male patients between the ages of 6 and 15 years will be recruited. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) SE (Ongoing) DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002099-15 | Sponsor Protocol Number: APOCT-001 | Start Date*: 2014-09-15 | |||||||||||
Sponsor Name:Apodemus AB | |||||||||||||
Full Title: A randomised, double blind, placebo controlled trial to evaluate the safety and efficacy of Apovir for treatment of patients with Amyotrophic lateral sclerosis | |||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis (ALS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002126-23 | Sponsor Protocol Number: APOCT-002 | Start Date*: 2013-09-06 | |||||||||||
Sponsor Name:Apodemus AB | |||||||||||||
Full Title: A randomized, double blind, placebo controlled trial to evaluate the safety and efficacy of Apovir for treatment of patients with Alzheimer’s disease | |||||||||||||
Medical condition: Alzheimer's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
